MSA is an abbreviation used across several fields, and its “purpose” depends on the context. The three most common meanings are Mannitol Salt Agar (a lab medium used to identify bacteria), Multiple System Atrophy (a neurological diagnosis), and microsatellite analysis (a DNA testing technique). Here’s what each one is for and why it matters.
Mannitol Salt Agar (MSA) in Microbiology
Mannitol Salt Agar is a specially designed growth medium used in microbiology labs to isolate and identify Staphylococcus aureus, one of the most common disease-causing bacteria. It serves two purposes at once: it’s both selective (it blocks unwanted bacteria from growing) and differential (it visually distinguishes one type of bacterium from another on the same plate).
The selective power comes from a very high salt concentration, 7.5% sodium chloride, which creates osmotic pressure that kills off most gram-positive and gram-negative bacteria. Staphylococci can tolerate this salt level, so they survive and form colonies while everything else is suppressed. This is especially useful when working with specimens that contain a complex mix of bacteria, like respiratory samples from patients with cystic fibrosis, where normal flora would otherwise make it difficult to spot dangerous organisms.
The differential function relies on mannitol, the only sugar in the medium, paired with a pH indicator called phenol red. When a bacterium ferments mannitol, it produces acid, which drops the pH and turns the area around the colony bright yellow. S. aureus ferments mannitol and produces this color change. Other staphylococci that can survive the salt but don’t ferment mannitol leave the surrounding agar its original red or pink color. So a lab technician can look at a plate and immediately distinguish S. aureus (yellow zones) from less dangerous coagulase-negative staphylococci (red/pink zones) without running additional tests.
What’s in the Medium
A standard MSA plate contains beef extract and peptone as nutrient sources, 75 grams of sodium chloride per liter (creating that critical 7.5% salt concentration), 10 grams of mannitol, a trace of phenol red as the indicator dye, agar for solidification, and distilled water. The recipe is simple, but the combination makes it one of the most widely used selective media in clinical and teaching laboratories.
Multiple System Atrophy as a Diagnosis
In medicine, MSA stands for Multiple System Atrophy, a progressive neurodegenerative disease. The purpose of diagnosing MSA is to distinguish it from similar-looking conditions, particularly Parkinson’s disease, because the two have overlapping symptoms but very different trajectories and treatment responses. MSA affects roughly 7 to 12 people per 100,000 in the United States, depending on how cases are counted, and it progresses faster than most other neurodegenerative disorders.
What MSA Does to the Body
MSA attacks multiple body systems simultaneously. Its hallmark is the buildup of a misfolded protein called alpha-synuclein inside support cells in the brain called oligodendrocytes. These protein clumps, known as glial cytoplasmic inclusions, are unique to MSA and not found in other neurodegenerative diseases. As they accumulate, they damage surrounding nerve tissue, triggering widespread degeneration in the brain and spinal cord. The resulting damage shows up in three broad ways: movement problems, coordination problems, and failure of the body’s automatic functions.
Autonomic failure is often the earliest and most disabling feature. It includes a sharp drop in blood pressure upon standing (orthostatic hypotension, sometimes severe enough to cause fainting), urinary incontinence or retention, constipation, and erectile dysfunction in men. These symptoms typically appear before the more recognizable movement problems.
Two Subtypes of MSA
Doctors classify MSA into two subtypes based on which movement symptoms dominate. MSA-P (parkinsonian type) primarily causes rigidity, slowness of movement, postural instability, and tremor. It resembles Parkinson’s disease but responds poorly to the standard Parkinson’s medication levodopa. MSA-C (cerebellar type) primarily causes problems with coordination: unsteady gait, clumsy limb movements, slurred speech, and abnormal eye movements. Cerebellar symptoms appear in all MSA-C patients and about half of MSA-P patients, while parkinsonian symptoms show up in nearly all MSA-P patients and about 74% of MSA-C patients. The overlap is significant, which is why diagnosis can be challenging.
Both subtypes share a grim timeline. Average survival from symptom onset is about 8 to 9 years. Onset typically occurs in the mid-50s, and deterioration is rapid compared to Parkinson’s, which can progress over decades. Treatment for MSA is entirely symptom-based. There is no therapy that slows or stops the underlying protein accumulation.
Microsatellite Analysis in DNA Testing
In genetics and forensics, MSA refers to microsatellite analysis, a technique that examines short, repeating sequences of DNA called short tandem repeats (STRs). These repeating segments vary in length from person to person, making them powerful tools for identification.
The primary purpose of microsatellite analysis in forensics is to match a DNA sample to a specific individual. Because STR markers are highly variable across the population, analyzing a small set of them (the U.S. CODIS database uses 20 markers) can produce a profile that is essentially unique. This is the foundation of forensic DNA profiling used in criminal investigations and paternity testing. When the CODIS marker set was expanded from 13 to 20 markers, designers specifically chose markers that would not reveal medical or physical traits, keeping the system focused on identification rather than health prediction.
In oncology, microsatellite analysis serves a different purpose. Tumors sometimes develop a defect in their DNA repair machinery, leading to changes in the length of microsatellite sequences. This condition, called microsatellite instability, is a marker for certain cancers, particularly colorectal cancer. Detecting it helps guide treatment decisions, since tumors with high microsatellite instability often respond well to immunotherapy.